Time trends in the use of β-blockers and other pharmacotherapies in older adults with congestive heart failure

This publication has 17 references indexed in Scilit:

• Lifetime Risk for Developing Congestive Heart Failure
  Circulation, 2002
• Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials
  JACC, 2002
• β-Blockers in Congestive Heart Failure: A Bayesian Meta-Analysis
  Annals of Internal Medicine, 2001
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
  New England Journal of Medicine, 1997
• Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
  JAMA, 1995
• Recruitment of adults 65 years and older as participants in the cardiovascular health study
  Annals of Epidemiology, 1993
• A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
  New England Journal of Medicine, 1991
• The cardiovascular health study: Design and rationale
  Annals of Epidemiology, 1991
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
  New England Journal of Medicine, 1986